Literature DB >> 17215652

Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment.

William B White1.   

Abstract

Ambulatory blood pressure (BP) monitoring has matured into a useful methodology that obtains automated measurements of brachial artery BP during a 24-hour period. Cardiovascular outcomes in the treated patient with hypertension are often better predicted by ambulatory BP than by office pressures. Consensus guidelines have advocated lower goals of treated office BP in the majority of patients with hypertension; guidelines for the goal of ambulatory BP are needed as well. Recently, prospective cohort studies have shown that individuals whose clinic pressure is relatively normal but whose 24-hour BP is elevated are more likely to have a cardiovascular event than individuals with both normal clinic BP and ambulatory BP. Along with the knowledge gained from analyses of higher-risk hypertension patients, recommendations can now be made for how to use ambulatory BP monitoring in clinical practice. For example, ambulatory BP monitoring may be useful in verifying 24-hour control in high-risk patients whose office BP appears to be normal at rest or during the peak effect time of their antihypertensive agents. Evidence is mounting from studies that support the use of ambulatory BP monitoring in patients with resistant hypertension at the time of diagnosis and following clinically guided therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215652      PMCID: PMC8110082          DOI: 10.1111/j.1524-6175.2007.06345.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  15 in total

1.  Ambulatory blood-pressure monitoring in clinical practice.

Authors:  William B White
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

2.  Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension.

Authors:  William B White
Journal:  Hypertension       Date:  2005-12-12       Impact factor: 10.190

3.  Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension.

Authors:  G Schillaci; P Verdecchia; C Borgioni; A Ciucci; R Gattobigio; N Sacchi; G Benemio; C Porcellati
Journal:  J Hypertens       Date:  1996-10       Impact factor: 4.844

4.  Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.

Authors:  William B White; Daniel Duprez; Richard St Hillaire; Scott Krause; Barbara Roniker; Janice Kuse-Hamilton; Michael A Weber
Journal:  Hypertension       Date:  2003-04-07       Impact factor: 10.190

5.  Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo; José E López; Artemio Mojón; María J Fontao; Rita Soler; José R Fernández
Journal:  Hypertension       Date:  2005-08-08       Impact factor: 10.190

6.  Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism.

Authors:  G A Mansoor; W B White
Journal:  Hypertension       Date:  1998-03       Impact factor: 10.190

7.  Effects of eplerenone versus losartan in patients with low-renin hypertension.

Authors:  Myron H Weinberger; William B White; Luis-Miguel Ruilope; Thomas M MacDonald; Robert C Davidson; Barbara Roniker; Jeffrey L Patrick; Scott L Krause
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

8.  Management of hypertension after ambulatory blood pressure monitoring.

Authors:  J M Grin; E J McCabe; W B White
Journal:  Ann Intern Med       Date:  1993-06-01       Impact factor: 25.391

9.  Characterization of antihypertensive therapy by whole-day blood pressure monitoring.

Authors:  M A Weber; D G Cheung; W F Graettinger; J L Lipson
Journal:  JAMA       Date:  1988-06-10       Impact factor: 56.272

10.  Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns.

Authors:  R Fogari; A Zoppi; G D Malamani; P Lazzari; M Destro; L Corradi
Journal:  Am J Hypertens       Date:  1993-01       Impact factor: 2.689

View more
  3 in total

1.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 2.  Resistant hypertension.

Authors:  Sheldon W Tobe; Richard Lewanczuk
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

3.  Ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Dimitrios Syrseloudis; Ioannis Andrikou; Eirini Andrikou; Kyriakos Dimitriadis; Christodoulos Stefanadis
Journal:  Int J Hypertens       Date:  2011-04-05       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.